31 filings
8-K
EIDX
Eidos Therapeutics, Inc.
26 Jan 21
Entry into a Material Definitive Agreement
8:46am
8-K
EIDX
Eidos Therapeutics, Inc.
20 Jan 21
Submission of Matters to a Vote of Security Holders
4:23pm
8-K
EIDX
Eidos Therapeutics, Inc.
12 Jan 21
Other Events
7:31am
8-K
EIDX
Eidos Therapeutics, Inc.
29 Oct 20
Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business Update
4:30pm
8-K
EIDX
Eidos Therapeutics, Inc.
6 Oct 20
Entry into a Material Definitive Agreement
9:35pm
8-K
znwe4cgw6zur uyx
5 Oct 20
Bridgebio Pharma and Eidos Therapeutics Announce Merger Agreement
4:06pm
8-K
iqhjzlz9wypoq8d
29 Sep 20
Regulation FD Disclosure
7:15am
8-K
f50s34dcjk7ckvte
7 Aug 20
Eidos Therapeutics Appoints Industry Leaders With Significant Development and Commercial Expertise to Board of Directors
4:56pm
8-K
u3qud 9f0fr2byf4
6 Aug 20
Eidos Therapeutics Reports Second Quarter 2020 Financial Results and Business Update
4:33pm
8-K
7psz1osme6cd14beh50
1 Jun 20
Departure of Directors or Certain Officers
4:05pm
8-K
fkz2nt nyi05fsj
8 May 20
Eidos Therapeutics Reports First Quarter 2020 Financial Results and Business Update
4:30pm
8-K
bporn8
24 Mar 20
Other Events
6:06am
8-K
ydg 5cjwrqpccv
26 Feb 20
Eidos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Business Update
4:30pm
8-K
jhav j6mv6eio8
7 Jan 20
Departure of Directors or Certain Officers
4:48pm
8-K
ukbe 6k6t4vjujmkyyq
17 Dec 19
Departure of Directors or Certain Officers
4:03pm
8-K
znc42yx2
18 Nov 19
Entry into a Material Definitive Agreement
8:01am
8-K
vhmb tf8lf05x
31 Oct 19
Eidos Therapeutics Reports Third Quarter 2019 Financial Results and Business Update
4:30pm
8-K
svou9 63ov9
13 Sep 19
Eidos Therapeutics Special Committee Rejects Proposal from BridgeBio Pharma to Acquire Shares
4:05pm
8-K
ooz53ueg
11 Sep 19
Entry into a Material Definitive Agreement
4:36pm
8-K
go91s b2x1n9o8r
12 Aug 19
Eidos Therapeutics Confirms Receipt ofNon-Binding Proposal from BridgeBio Pharma to Acquire Shares
4:27pm